0.7726
2.81%
-0.0224
Quoin Pharmaceuticals Ltd ADR (QNRX) 最新ニュース
Quoin Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 9, 2024
GlobeNewswire Inc.
Maxim Group Maintains Buy Rating for Quoin Pharmaceuticals: Here's What You Need To Know
Benzinga
Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial Results
GlobeNewswire Inc.
Quoin Pharmaceuticals Announces Fourth Quarter and 2023 Financial Results and Corporate Update Conference Call to be held on Thursday March 14th at 8:30 am ET
GlobeNewswire Inc.
Crude Oil Down 1%; Dave Shares Jump After Q4 Results
Benzinga
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Nasdaq Down 250 Points; ISM Services PMI Falls In February
Benzinga
Dow Dips Over 100 Points; Target Posts Upbeat Earnings
Benzinga
Why Paymentus Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Benzinga
Crude Oil Down Over 1%; Quoin Pharmaceuticals Shares Spike Higher
Benzinga
Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga
Gold Gains 1%; JOANN Shares Plummet
Benzinga
Dow Falls Over 100 Points; Sea Posts Upbeat Sales
Benzinga
Quoin Pharmaceuticals Announces FDA Clearance of Clinical Optimization Plan for QRX003 for Netherton Syndrome
GlobeNewswire Inc.
大文字化:
|
ボリューム (24 時間):